Consolidated Statements of Operations - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Net Sales	$ 4,601	$ 4,178
Cost of Goods Sold	2,724	2,420
Research and Development Expense	268	281
Selling, General and Administrative Expenses	735	733
Amortization of Intangibles	179	183
Restructuring and Asset related charges, net	5	100
Other income - net	17	337
Interest Expense	9	7
Income from continuing operations before income taxes	698	791
Provision for (benefit from) income taxes on continuing operations	121	178
Income from continuing operations after income taxes	577	613
Income (loss) from discontinued operations after income taxes	(10)	(10)
Net income	567	603
Net income attributable to noncontrolling interests	3	3
Net income attributable to Corteva	$ 564	$ 600
Basic earnings (loss) per share of common stock from continuing operations	$ 0.79	$ 0.82
Basic earnings (loss) per share of common stock from discontinued operations	(0.01)	(0.01)
Basic earnings (loss) per share of common stock	0.78	0.81
Diluted earnings (loss) per share of common stock from continuing operations	0.79	0.81
Diluted earnings (loss) per share of common stock from discontinued operations	(0.01)	(0.01)
Diluted earnings (loss) per share of common stock	$ 0.78	$ 0.80
EID [Member]
Net Sales	$ 4,601	$ 4,178
Cost of Goods Sold	2,724	2,420
Research and Development Expense	268	281
Selling, General and Administrative Expenses	735	733
Amortization of Intangibles	179	183
Restructuring and Asset related charges, net	5	100
Other income - net	17	337
Interest Expense	18	22
Income from continuing operations before income taxes	689	776
Provision for (benefit from) income taxes on continuing operations	119	174
Income from Continuing Operations After Taxes	570	602
Income (loss) from discontinued operations after income taxes	(10)	(10)
Net income	560	592
Net income attributable to noncontrolling interests	1	1
Net income attributable to Corteva	$ 559	$ 591